INO vs RBLX · $88.0M cap vs rev $2.91B
Inovio Pharmaceuticals Inc (INO) versus Roblox Corp (RBLX) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Roblox Corp (RBLX) is a electronic gaming & multimedia company listed on US. It is led by David Baszucki.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported RBLX revenue for 2026-06-30 was $2.91B. Net income was -$429.0M. RBLX currently screens at market cap $68.27B.
INO currently screens at market cap $88.0M. RBLX currently screens at market cap $68.27B.
Not investment advice. Open the INO and RBLX stock pages for the full models.
Not investment advice.